FDA Improvement Act Introduced In House
Legislation has been introduced into the U.S. House of Representatives that would bar the U.S. Food and Drug Administration from collecting drug user fees that manufacturers pay to seek the agency's...To view the full article, register now.
Already a subscriber? Click here to view full article